Lania Tablet

Adult dose

Take 1 tablet daily for 21 days, followed by a 7-day break. It is recommended to take it at the same time every day. Start taking it from the first day of your period and continue taking it daily for 21 days, followed by a 7-day break. After the 7-day break, start taking it again the next day. If you forget to take a tablet, take it as soon as you remember and continue taking it as you were before. If you forget to take 2 tablets during the first or second week, take the 2 tablets immediately.

This medication may significantly increase the risk of serious cardiovascular side effects, particularly thrombosis, in women who smoke, so smoking should be avoided. In particular, women over the age of 35 who smoke should not take this medication. This medicine should not be administered to patients with certain conditions. For example, in cases of estrogen-dependent tumors or suspected breast cancer, history of thrombosis or cardiovascular disease, moderate to severe hypertension, liver dysfunction, during pregnancy, or while breastfeeding, this medication should not be taken. Also, patients with lactose intolerance or specific metabolic genetic disorders should avoid this medication. This drug should be administered cautiously in some patients, and smokers, patients with hypertension, obesity, women over 40, patients with migraines or epilepsy, and those with valvular heart disease need a consultation with a doctor and caution before taking it. Cardiovascular adverse reactions such as thrombosis, stroke, myocardial infarction can occur while taking this medication, and various side effects such as menstrual irregularities, breast-related symptoms, gastrointestinal disturbances, central nervous system symptoms, skin rashes, visual and auditory impairments, and metabolic abnormalities can appear. Regularly check blood pressure, breasts, and cervical examinations while taking this medication, and consult a doctor immediately if any abnormal symptoms occur. This drug can interact with other medications, and the contraceptive effect may be reduced when taken with certain medications, so additional non-hormonal contraceptive methods should be used. If you are pregnant or may become pregnant, you should stop taking this medication, and it is also advisable for breastfeeding women not to take this medicine. In cases of overdose, symptoms such as nausea, vomiting, dizziness, and drowsiness may occur, and treatment should be provided as needed depending on the symptoms. This drug can influence endocrine and liver function test results, so this should be taken into consideration during tests. Store this medication in a container that does not allow light, out of children's reach, and keep it in its original container, as transferring it to another container may lead to accidents or quality degradation. The risk of thrombosis is highest during the first year after starting this medication, so particular caution is needed during the initial phase of use.

Serious side effects

Thromboembolic venous events, thrombosis, arterial thromboembolism, stroke, cerebral hemorrhage, cerebral thrombosis, myocardial infarction, pulmonary embolism, severe allergic reactions (urticaria, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor), severe skin adverse reactions (severe rash accompanied by high fever, blisters, skin peeling, pain in oral/ocular mucosa), respiratory problems (shortness of breath or difficulty breathing, asthma attacks, accompanied by cough and fever), liver abnormalities.

Mild side effects

• Intermenstrual bleeding
• changes in menstrual flow and amenorrhea
• vaginal discharge changes
• increase in uterine fibroid size
• cervical erosion
• vaginal candidiasis
• vaginitis
• premenstrual syndrome
• dysmenorrhea
• breast tenderness and enlargement

Drug interactions

Do not take this medication with direct-acting antiviral drugs for hepatitis C (e.g., Ombitasvir, Paritaprevir, ritonavir combination, etc.), phenytoin, barbiturates, primidone, carbamazepine, rifampicin, lupinavir, aprepitant, bosentan, efavirenz, oxcarbazepine, topiramate, felbamate, griseofulvin, and St. John's wort, cholesterol-lowering medications, and antibiotics.

Food interactions

Do not take this medication with grapefruit juice.

This medication is sensitive to light, so it should be stored in a container that does not allow light to enter. Additionally, it is advisable to store it at room temperature between 1 to 30 degrees Celsius. This will help maintain the effectiveness of the medication.

Appearance

Pink round film-coated tablet

Package unit

21 tablets (21 tablets/PTP)